Viney Joanne L. 4
4 · Sionna Therapeutics, Inc. · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
Sionna (SION) Director Joanne L. Viney Receives 17,340-Share Award
What Happened
- Joanne L. Viney, a director of Sionna Therapeutics, was granted a derivative award representing 17,340 shares on June 17, 2026. The reported acquisition price is $0.00, so no cash was paid at grant and no immediate market value was realized by the insider.
Key Details
- Transaction date: 2026-06-17; filing date: 2026-06-18 (timely filing).
- Transaction type/code: A (Award/Grant, derivative).
- Shares granted: 17,340; reported price: $0.00; reported transaction value: $0.
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Footnote: The award vests in full upon the earlier of June 17, 2027 or the date of Sionna’s next annual meeting, subject to Viney’s continued service on the vesting date.
Context
- This is a time-based equity award (derivative) that vests in the future rather than an open-market purchase or sale. It does not represent an immediate buy/sell market signal and requires continued service to vest.
Insider Transaction Report
Form 4
Viney Joanne L.
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
[F1]2026-06-17+17,340→ 17,340 totalExercise: $36.73Exp: 2036-06-16→ Common Stock (17,340 underlying)
Footnotes (1)
- [F1]This option vests in full upon the earlier of June 17, 2027 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date.
Signature
By: Jennifer Fitzpatrick, Attorney-in-Fact For: Joanne Viney|2026-06-18